• Histology-driven taxonomy and developmental neuroglia knowledge underpin early neuro-oncology, guiding glioma classifications and cell-type concepts [2], [20], [8], [7].

• Oligodendroglial tumors emerge as a distinct cellular entity, with lineage tracing, histology, and multiple case reports consolidating their identity as oligodendroglial gliomas [1], [18], [19], [3].

• Clinical localization and symptom mapping across brain tumors reveal robust neuroanatomical correlations and varied progression, informing diagnostic framing [4], [15], [14], [16].

• Therapeutic approaches and radiobiology begin shaping management, with irradiation studies and large surgical series shaping expectations for outcomes [10], [11], [16].

• Peripheral and meningeal tumor biology connects CNS and peripheral nerve tumors, informing pathology, classification, and broader neurosurgical pathology [7], [20], [9], [5].